Latest Period
Q1 2026
Security Snapshot
Korro Bio, Inc. - Common Stock, par value $0.001 per share (the "Shares") Institutional Ownership
CUSIP: 500946108
13F Institutional Holders and Ownership History from Q4 2023 to Q1 2026
Institutions Reporting
3
Shares (Excl. Options)
1,601,162
Price
$11.32
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Type / Class
- Equity / Common Stock, par value $0.001 per share (the "Shares")
- Shares outstanding
- 9,480,333
- Price per share
- $11.32
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 1,601,162
- Total reported value
- $18,125,155
- Share change
- 0
- Number of holders
- 3
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Key facts
- 500946108 - Korro Bio, Inc. - Common Stock, par value $0.001 per share (the "Shares") is tracked under CUSIP 500946108.
- 3 institutions reported positions in Q1 2026.
- 1 significant owner is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 4 to 3 between Q4 2025 and Q1 2026.
- Reported value moved from $6,160,403 to $18,125,155.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 3 institutions filings for Q1 2026.
Security key
500946108
Latest holder period
Q1 2026
13F holders
3
13D/G owners
1
CIK / CUSIP context first
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 500946108:
Significant Owners of Korro Bio, Inc. - Common Stock, par value $0.001 per share (the "Shares") based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| CITADEL ADVISORS LLC | 3.9% | 369,733 | Citadel Advisors LLC | 31 Dec 2024 |
As of 31 Mar 2026, 3 institutional investors reported holding 1,601,162 shares of Korro Bio, Inc. - Common Stock, par value $0.001 per share (the "Shares"). This represents 17% of the company’s total 9,480,333 outstanding shares.
Top 3 Institutional Shareholders
The largest institutional shareholders of Korro Bio, Inc. - Common Stock, par value $0.001 per share (the "Shares") together control 17% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Lynx1 Capital Management LP | 16% | 1,538,296 | 0% | 2.8% | $17,413,511 |
| EMERALD MUTUAL FUND ADVISERS TRUST | 0.66% | 62,855 | 0% | 0.04% | $711,519 |
| FIFTH THIRD BANCORP | 0% | 11 | 0% | 0% | $125 |
Institutional Holders of Korro Bio, Inc. - Common Stock, par value $0.001 per share (the "Shares") across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 1,601,162 | $18,125,155 | $11.32 | 3 | |
| 2025 Q4 | 769,089 | $6,160,403 | +$508,266 | $8.01 | 4 |
| 2024 Q3 | 118,765 | $3,969,126 | +$630,869 | $33.42 | 1 |
| 2024 Q2 | 506,269 | $17,147,331 | +$13,803,651 | $33.87 | 2 |
| 2024 Q1 | 98,721 | $8,884,890 | +$674,370 | $90.00 | 2 |
| 2023 Q4 | 91,228 | $4,372,557 | $47.93 | 2 |